Life Science DailyRadiation Boosts Immunotherapy Benefit in NSCLCMedscapeCompelling evidence that prior radiotherapy enhances the antitumor effects of immunotherapy in patients with non-small cell lung cancer (NSCLC) could expand the use of immunothera… Continue reading
|
Molecule Can Mask Cancer’s Pain, Helping the Disease Develop, Study Shows
Immuno-Oncology News The PD-L1 molecule can mask cancer’s pain, enabling malignancies to develop and spread without sending alarms to the immune system, according to a study. Researchers from Duke University School of Medicine discovered that Opdivo (nivolumab) fights … |
Financial Times |
Big pharma turns to immunotherapy combos to beat cancer
Financial Times Merck last week became the first company to win approval to use its immunotherapy Keytruda in all patients whose tumours have a particular biological trait or “biomarker”, regardless of where the cancer is located. At Asco, it is due to present full … |